Recent Cancer Australia grant outcomes
2010
Priority-driven Collaborative Cancer Research Scheme
Chen Y
The Children’s Hospital at Westmead
Tumor protein D52 overexpression and DNA repair in cancer
Co-funded by Cure Cancer Australia Foundation and Cancer Australia
Davidson A
University of Sydney – Clinical Trials Centre
NITRO - A randomised, phase III trial of adding nitroglycerin to first line chemotherapy for advanced non-small cell lung cancer
Funded by Cancer Australia
Fogarty G
University of Sydney
Whole Brain Radiotherapy following local treatment of intracranial metastases of melanoma – a randomised phase III trial
Funded by Cancer Australia
Henson J
Children's Medical Research Institute
Alternative Lengthening of Telomeres (ALT) in lung cancer: analysis of effects on patient outcomes and development of a blood test
Co-funded by Cure Cancer Australia Foundation and the National Lung Cancer Program
Hilton H
Westmead Institute for Cancer Research
The impact of aberrant progesterone signalling on lineage specification during early malignant transformation
Co-funded by Cure Cancer Australia Foundation and Cancer Australia
2009
Priority-driven Collaborative Cancer Research Scheme
De Fazio A
Westmead Institute for Cancer Research
Genomic determinants of chemosensitivity in ovarian cancer
Funded by Cancer Australia
Hahn M
Kolling Institute of Medical Research
A link between p53, RNF20 and parafibromin in malignancy
Funded by Cure Cancer Australia Foundation
Horvath L
Sydney Cancer Centre
Identifying and targeting Docetaxel resistance in hormone refractory prostate cancer
Co-funded by Prostate Cancer Foundation of Australia and Cancer Australia
Huang X
University of Sydney
hOGG1 in human skin carcinogenesis
Co-funded by Cure Cancer Australia Foundation of Australia and Cancer Australia
Napier C
Children’s Medical Research Institute
Ku: a potential repressor of the ALT telomere maintenance mechanism
Funded by Cure Cancer Australia Foundation of Australia
Pickett H
Children’s Medical Research Institute
Telomere trimming: a novel mechanism for preventing unlimited cellular proliferation
Co-funded by Cure Cancer Australia Foundation of Australia and Cancer Australia
Soon P
Kolling Institute of Medical Research
The role of microRNAs in the progression of ductal carcinoma in situ to invasive breast cancer
Co-funded by Cure Cancer Australia Foundation of Australia and Cancer Australia
Trevena L
University of Sydney
Randomised trial of consumer-led familial cancer risk tool & GP triage on risk-appropriate colorectal cancer screening
Funded by Cancer Australia
2008
Priority-driven Collaborative Cancer Research Scheme
Kilbreath S
Incidence and risk factors for lymphoedema secondary to breast cancer: a prospective cohort study
Co-funded by the National Breast Cancer Foundation and Cancer Australia
Kilbreath S
Clinical correlates of lymphoedema
Funded by the National Breast Cancer Foundation
Markus A
Genome-wide analysis of pre-mRNA splicing regulation by RBM4
Co-funded by Cure Cancer Australia Foundation and Cancer Australia
Olver I
Understanding the psychosocial sequelae of surviving testicular cancer
Co-funded by beyondblue and Cancer Australia
Young J
Quality of life outcomes and cost effectiveness of pelvic exenteration for people with advanced rectal cancer
Co-funded by Cancer Council Australia and Cancer Australia
2007
Priority-driven Collaborative Cancer Research Scheme
Kilbreath S
Prevention of osteoporosis as a consequence of hormone treatment in postmenopausal women treated for breast cancer
Co-funded by Cancer Australia and the National Breast Cancer Foundation
Price T
Preop chemoradiotherapy&postop chemo with capecitabine&oxaliplatin vs. capecitabine alone in locally advanced rectal cancer
Funded by Cancer Australia